Hunan Er-Kang Pharmaceutical Co.
Established in Oct., 2003, Hunan Er-kang Pharmaceutical Co., Ltd. (refered as ¡°EK¡±) is a high-tech corporation which is located in National Biomedical Industry Base of Changsha, Hunan province. Since the setting up, EK is dedicated in the sale, production and research of the products which is in the scale of pharmaceutical excipients, new-type antibiotics and other API. EK has passed GMP certificate twice in April and October, 2004. he company chairman of the board, Dr. Shuai Fang Wen was awarded as the professor of Central South University of China in13th May£¬2011. At the same time, to win-win situation for research£¬Central South University established a ¡°Teaching Base¡± in EK company. In 2th July, 2012, Dr. Shuai Fang Wen was invited by The United States Pharmacopoeia Commission as the member of East Asia expert committee. The main mission is to establish the standard and monograph of modern pharmaceutical excipient combining to the safety. Leading by Dr. Shuai Fang Wen, EK became the biggest producer of pharmaceutical excipients in China and the company was listed in ShenZhen stock market as the first listed company in pharmaceutical excipient industry ( the stock code is 300267). Er-Kang has over 3000 customers in China (All China has about over 4000 pharmaceutical company), and owns the 75% domestic market share. At present, EK has over 120 pharmaceutical excipients and 46 APIs. The company¡¯s production area covers an area of about 87,000 m2£¬about 50,000 m2 of green area£¬where the clean area covers about 3,000m2. The company is equipped with 275 major Pharmaceutical mechanical, 45 test instruments and complete various supporting facilities, able to finish the production and test of all products. EK believes in "Concordancy, Faithfulness, Sedulity, Performance"£» takes qualified personnel as a fundamental£¬relies on high-tech£¬adheres strive for survival on the basis of quality, customer-centric, provides domestic pharmaceutical industry with high-quality bulk drug pharmaceutical excipients.
About Hunan Er-Kang Pharmaceutical Co.
Estimated Revenue
$250M-$500MEmployees
1K-5KCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
44Location
City
ChangshaState
HunanCountry
ChinaHunan Er-Kang Pharmaceutical Co.
Find your buyer within Hunan Er-Kang Pharmaceutical Co.